TRAX
First Tracks Biotherapeutics Inc NASDAQ Listed Apr 20, 2026$40.46
-4.82%
vs $42.51
Mkt Cap $1.4B
52w Low $14.72
73.1% of range
52w High $49.91
50d MA $37.69
200d MA $27.76
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
—
ROE
—
P/FCF
—
RSI (14)
43.10
ATR (14)
$2.77
Beta
0.00
50d MA
$37.69
200d MA
$27.76
Avg Volume
697.7K
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
10770 WATERIDGE CIRCLE · San Diego, CA 92121 · US
Data updated apr 27, 2026 5:29am
· Source: financialmodelingprep.com